Literature DB >> 30121816

Genetic Risk Factors for Intracranial Aneurysm in the Kazakh Population.

Elena V Zholdybayeva1, Yerkin Z Medetov2, Akbota M Aitkulova3,4, Yerbol T Makhambetov2, Serik K Akshulakov2, Assylbek B Kaliyev2, Yerkebulan A Talzhanov3, Gulmira N Kulmambetova3, Aisha N Iskakova3, Yerlan M Ramankulov3,5.   

Abstract

An intracranial aneurysm (IA) is a weak or thin area on a blood vessel in the brain that balloons as it fills with blood. Genetic factors can influence the risk of developing an aneurism. The purpose of this study was to explore the relationship between single nucleotide polymorphisms (SNPs) and IA in Kazakh population. The patients were genotyped for 60 single nucleotide polymorphisms. Genotyping was performed on the QuantStudio 12K Flex (Life Technologies). A linear regression analysis found 13 SNPs' significant association with development and rupture of IA: the rs1800956 polymorphism of the ENG gene, rs1756 46 polymorphism of the JDP2 gene, variant rs1800255 of the COL3A1, rs4667622 of the UBR3, rs2374513 of the c12orf75, rs3742321 polymorphism of the StAR, the rs3782356 polymorphism of MLL2 gene, rs3932338 to 214 kilobases downstream of PRDM9, rs7550260 polymorphism of the ARHGEF, rs1504749 polymorphism of the SOX17, the rs173686 polymorphism of CSPG2 gene, rs6460071 located on LIMK1 gene, and the rs4934 polymorphism of SERPINA3. A total of 13 SNPs were identified as potential genetic markers for the development and risk of rupture of aneurysms in the Kazakh population. Similar results were obtained after adjusting for the confounding factors of arterial hypertension and age.

Entities:  

Keywords:  Genotyping; Intracranial aneurysm; Risk factors; Ruptured and unruptured aneurysms; SNP

Mesh:

Substances:

Year:  2018        PMID: 30121816     DOI: 10.1007/s12031-018-1134-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  7 in total

1.  Activated leukocyte cell adhesion molecule/cluster of differentiation 166 rs10933819 (G>A) variant is associated with familial intracranial aneurysms.

Authors:  Akbota Aitkulova; Kymbat Mukhtarova; Elena Zholdybayeva; Yerkin Medetov; Botagoz Dzhamantayeva; Kuat Kassymbek; Talgat Utupov; Ilyas Akhmetollayev; Serik Akshulakov; Gulmira Kulmambetova; Yerlan Ramankulov
Journal:  Biomed Rep       Date:  2022-06-07

Review 2.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

3.  Associations between Inflammatory Cytokine Gene Polymorphisms and Susceptibilities to Intracranial Aneurysm in Chinese Population.

Authors:  Lu Xu; Liming Hu; Chongyu Hu; Junyu Liu; Bingyang Li; Xin Liao; Jilin Zhou; Songlin Liu; Yifeng Li; Dun Yuan; Weixi Jiang; Junxia Yan
Journal:  Biomed Res Int       Date:  2021-01-16       Impact factor: 3.411

4.  Comparative analysis of aneurysm subtypes associated genes based on protein-protein interaction network.

Authors:  Ruya Sun; Yuan Zhou; Qinghua Cui
Journal:  BMC Bioinformatics       Date:  2021-12-11       Impact factor: 3.169

5.  Association of Versican Gene Polymorphisms with Intracranial Aneurysm Susceptibility in the Eastern Chinese Population.

Authors:  Lei Zhu; Chuanqing Yu; Shuping Zhou; Min Xue; Jie Chen; Meijun Wu; Shuyang Dong; Guanmin Huang; Yueyue Chang; Mei Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-07       Impact factor: 2.570

6.  LncRNA SAMMSON Overexpression Suppresses Vascular Smooth Muscle Cell Proliferation via Inhibiting miR-130a Maturation to Participate in Intracranial Aneurysm.

Authors:  Wen Pan; Yuan Gao; Weifeng Wan; Wenfeng Xiao; Chao You
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-04       Impact factor: 2.570

Review 7.  The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis.

Authors:  Huahui Liu; Wen Huang
Journal:  Iran J Public Health       Date:  2019-11       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.